December 8, 2025Blood

MRD-seq: A sensitive next generation sequencing-based approach for measurable residual disease detection in acute myeloid leukaemia

View Full Paper

Ask AI

Bookmark

Authors

MAMariam Alhilali PBPeter Browett SBStefan K. Bohlander

Discussion

Member takes

Overview

Observational analysis shows improved measurable residual disease detection in acute myeloid leukaemia, indicating clinical importance for treatment decisions.

Key Points

MRD-Seq yields high sensitivity in detecting residual disease in acute myeloid leukaemia, surpassing existing methods.
The next-generation sequencing approach detects somatic mutations with a sensitivity of up to 1 × 10⁻⁵ for specific mutations.
Analysis included validation using serial dilution of cell lines with established mutations for accuracy.
This method addresses the clinical need for efficient monitoring of disease management in patients with varying mutation profiles.

Cite This Study

Alhilali et al. (2025) studied this question.

synapsesocial.com/papers/69362f3d4fa91c937236d54a https://doi.org/10.1182/blood-2025-7046

View Full Paper

Ask AI

Bookmark

December 8, 2025Blood

MRD-seq: A sensitive next generation sequencing-based approach for measurable residual disease detection in acute myeloid leukaemia

View Full Paper

Ask AI

Bookmark

Authors

MAMariam Alhilali PBPeter Browett SBStefan K. Bohlander

Discussion

Member takes

Overview

Observational analysis shows improved measurable residual disease detection in acute myeloid leukaemia, indicating clinical importance for treatment decisions.

Key Points

MRD-Seq yields high sensitivity in detecting residual disease in acute myeloid leukaemia, surpassing existing methods.
The next-generation sequencing approach detects somatic mutations with a sensitivity of up to 1 × 10⁻⁵ for specific mutations.
Analysis included validation using serial dilution of cell lines with established mutations for accuracy.
This method addresses the clinical need for efficient monitoring of disease management in patients with varying mutation profiles.

Cite This Study

Alhilali et al. (2025) studied this question.

synapsesocial.com/papers/69362f3d4fa91c937236d54a https://doi.org/10.1182/blood-2025-7046

View Full Paper

Ask AI

Bookmark